Ostrum Asset Management’s ResMed RMD Stock Holding History

Ostrum Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$244K	Sell	1,089 -1,707	-61%	-$425K	0.01%	490
2025 Q4	$673K	Sell	2,796 -928	-25%	-$237K	0.03%	339
2025 Q3	$1.02M	Buy	3,724 +1,807	+94%	+$494K	0.05%	308
2025 Q2	$495K	Sell	1,917 -4,267	-69%	-$1.02M	0.02%	409
2025 Q1	$1.38M	Buy	6,184 +4,984	+415%	+$1.16M	0.07%	244
2024 Q4	$274K	Sell	1,200 -51	-4%	-$12.3K	0.02%	469
2024 Q3	$305K	Sell	1,251 -1,963	-61%	-$439K	0.03%	451
2024 Q2	$615K	Sell	3,214 -4,262	-57%	-$865K	0.05%	365
2024 Q1	$1.48M	Hold	7,476	–	–	0.12%	275
2023 Q4	$1.29M	Sell	7,476 -1,300	-15%	-$200K	0.11%	263
2023 Q3	$1.3M	Sell	8,776 -1,579	-15%	-$286K	0.12%	257
2023 Q2	$2.26M	Buy	10,355 +9	+0.1%	+$2.01K	0.19%	182
2023 Q1	$2.27M	Buy	+10,346	New	+$2.24M	0.2%	182

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ostrum Asset Management's RMD Position: Q1 2026 in Review

Ostrum Asset Management reduced its ResMed (RMD) stake by 61% in Q1 2026, selling an estimated $425K and leaving 1,089 shares worth $244K. The position accounts for 0.01% of the portfolio, ranked #490.

Ostrum Asset Management first reported a position in RMD in Q1 2023 and has held it in 13 quarters since. The position peaked at $2.27M in Q1 2023. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Ostrum Asset Management held 1,089 shares of ResMed worth $244K as of Q1 2026.
Ostrum Asset Management sold 1,707 ResMed shares in Q1 2026, an estimated $425K.
ResMed made up 0.01% of Ostrum Asset Management's portfolio in Q1 2026, its #490 holding.
Ostrum Asset Management first reported a position in ResMed in Q1 2023 and has held it in 13 quarters since.
Ostrum Asset Management's ResMed position peaked at $2.27M in Q1 2023.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Ostrum Asset Management's 13F filing for Q1 2026, filed 14 May 2026.